Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status

Nature Medicine

Volumn 22, Issue 6, 2016, Pages 577-578

  Schoumacher, Marie ^a,b   Le Corre, Stéphanie ^a,c   Houy, Alexandre ^a,d   Mulugeta, Eskeatnaf ^a,c   Stern, Marc Henri ^a,d   Roman Roman, Sergio ^a,b   Margueron, Raphaël ^a,c  

^a INSTITUT CURIE   (France)

^b Department of Translational Research ^*  (France)

^c INSERM   (France)

^d INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BAP1 PROTEIN; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; HISTONE H3; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

CANCER RESISTANCE; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; COLONY FORMING UNIT GM; HUMAN; LETTER; MELANOMA CELL; MESOTHELIOMA; MESOTHELIOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; UVEA MELANOMA; MELANOMA; UVEA TUMOR;

HUMANS; MELANOMA; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; UVEAL NEOPLASMS;

EID: 84976367402     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4098     Document Type: Letter

References (5)

1. LaFave, L.M. et al. Nat. Med. 21, 1344-1349 (2015).
2. Harbour, J.W. et al. Science 330, 1410-1413 (2010).
3. Margueron, R. & Reinberg, D. Nature 469, 343-349 (2011).
4. Amirouchene-Angelozzi, N. et al. Mol. Oncol. 8, 1508-1520 (2014).
5. Laurent, C. et al. Mol. Oncol. 7, 625-636 (2013).